Walsham, J <br/><br/>
The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery.  [electronic resource] 

 -  Anaesthesia and intensive care  Feb 2006 
 - 13-20 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0310-057X 
<br/><br/><label>Standard No.: </label>10.1177/0310057X0603400115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cardiac Surgical Procedures--adverse effects<br/>Cohort Studies<br/>Coronary Care Units<br/>Dose-Response Relationship, Drug<br/>Drainage--methods<br/>Factor VIIa--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Heart Transplantation--adverse effects<br/>Humans<br/>Infusions, Intravenous<br/>Lung Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Postoperative Hemorrhage--diagnosis<br/>Queensland<br/>Reoperation<br/>Retrospective Studies<br/>Risk Assessment<br/>Severity of Illness Index<br/>Survival Rate<br/>Thoracic Surgical Procedures--adverse effects<br/>Treatment Outcome